James P. Mackin - Mar 6, 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
President & CEO
Signature
/s/ James P. Mackin
Stock symbol
AORT
Transactions as of
Mar 6, 2025
Transactions value $
-$561,345
Form type
4
Date filed
3/10/2025, 05:18 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Award $0 +116K +15.18% $0.00 878K Mar 6, 2025 Direct F1
transaction AORT Common Stock Sale -$440K -17.7K -2.02% $24.80 860K Mar 6, 2025 Direct F2
transaction AORT Common Stock Options Exercise $1.63M +75.6K +8.79% $21.55 936K Mar 6, 2025 Direct F3
transaction AORT Common Stock Sale -$1.75M -70.7K -7.55% $24.76 865K Mar 6, 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -75.6K -100% $0.00 0 Mar 6, 2025 Common Stock 75.6K $21.55 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date.
F2 These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
F3 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024.
F4 Reflects weighted average price. Range of prices were between $24.40 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.